DK1988167T3 - Intracellulære inhiberende peptider - Google Patents

Intracellulære inhiberende peptider Download PDF

Info

Publication number
DK1988167T3
DK1988167T3 DK08102597.5T DK08102597T DK1988167T3 DK 1988167 T3 DK1988167 T3 DK 1988167T3 DK 08102597 T DK08102597 T DK 08102597T DK 1988167 T3 DK1988167 T3 DK 1988167T3
Authority
DK
Denmark
Prior art keywords
inhibitory peptides
intracellular inhibitory
intracellular
peptides
inhibitory
Prior art date
Application number
DK08102597.5T
Other languages
English (en)
Inventor
Jocelyne Caboche
Peter Vanhoutte
Original Assignee
Univ Sorbonne
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sorbonne, Centre Nat Rech Scient filed Critical Univ Sorbonne
Application granted granted Critical
Publication of DK1988167T3 publication Critical patent/DK1988167T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/095—Fusion polypeptide containing a localisation/targetting motif containing a nuclear export signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK08102597.5T 2005-02-17 2005-02-17 Intracellulære inhiberende peptider DK1988167T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08102597.5A EP1988167B1 (fr) 2005-02-17 2005-02-17 Peptides inhibiteurs intracellulaires
EP05290363A EP1693458A1 (fr) 2005-02-17 2005-02-17 Peptides inhibiteurs intracellulaires

Publications (1)

Publication Number Publication Date
DK1988167T3 true DK1988167T3 (da) 2020-07-13

Family

ID=35697129

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08102597.5T DK1988167T3 (da) 2005-02-17 2005-02-17 Intracellulære inhiberende peptider

Country Status (6)

Country Link
US (2) US20090215680A1 (da)
EP (2) EP1988167B1 (da)
JP (1) JP5612248B2 (da)
CA (1) CA2597020C (da)
DK (1) DK1988167T3 (da)
WO (1) WO2006087242A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110130346A1 (en) * 2008-05-30 2011-06-02 Isis Innovation Limited Peptide conjugates for delvery of biologically active compounds
EP2172209A1 (en) * 2008-10-03 2010-04-07 Universite Pierre Et Marie Curie Treatment of mood and anxiety disorders
SG187592A1 (en) 2010-07-23 2013-03-28 Univ Boston Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
WO2012016963A1 (en) 2010-08-02 2012-02-09 Fondazione Centro San Raffaele Del Monte Tabor Peptides for the treatment of brain diseases
US9139829B2 (en) * 2012-02-28 2015-09-22 Medical Diagnostic Laboratories, Llc SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment
WO2014127026A1 (en) * 2013-02-12 2014-08-21 National Jewish Health Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
CA2945037C (en) * 2014-04-08 2022-07-19 Inserm (Institut National De La Sante Et De La Recherche Medicale) Selective inhibitors of c-fos and their antiproliferative properties
EP3341413A4 (en) 2015-08-24 2019-07-17 Trustees of Boston University THERAPY AND IMAGING FOR CANCER AND STROKE ON MONOCLONAL ANTI-DESPR ANTIBODIES
AU2018333966B2 (en) 2017-09-18 2025-04-03 Trustees Of Boston University Methods for treating NETosis and neutrophil activation
GB201719520D0 (en) * 2017-11-24 2018-01-10 Univ College Cardiff Consultants Ltd Neuroprotectvie peptide
WO2019241609A1 (en) * 2018-06-15 2019-12-19 Trustees Of Boston University Polypeptide compositions and methods for site-specific targeting of therapeutic agents
US11584792B2 (en) 2020-10-15 2023-02-21 Trustees Of Boston University Antibody therapies and methods for treating coronavirus infection
FR3124509B1 (fr) 2021-06-25 2025-06-27 Melkin Pharmaceuticals Nouveaux inhibiteurs de phosphorylation de Elk-1 par ERK1/2
FR3124510B1 (fr) 2021-06-25 2025-10-24 Melkin Pharmaceuticals Nouveaux inhibiteurs de phosphorylation de Fos par ERK1/2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903408A3 (en) * 1992-08-21 2005-11-02 Biogen, Inc. Tat-derived transport polypeptide
US5589480A (en) 1994-08-17 1996-12-31 Elkhoury; George F. Topical application of opioid analgesic drugs such as morphine
JP3871713B2 (ja) * 1995-05-10 2007-01-24 協和醗酵工業株式会社 新規毒素複合体
CA2291074C (en) * 1997-05-21 2008-04-01 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
CA2364690A1 (en) * 1999-02-28 2000-10-19 Washington University Novel transduction molecules and methods for using same
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
FR2816845B1 (fr) * 2000-11-20 2006-10-20 Centre Nat Rech Scient Vecteurs de transport a travers un epithelium a jonctions serrees
US7244614B2 (en) * 2001-08-01 2007-07-17 Cellomics, Inc. Fusion proteins and assays for molecular binding
WO2004068139A2 (en) * 2003-01-10 2004-08-12 The Regents Of The University Of California Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes

Also Published As

Publication number Publication date
WO2006087242A3 (fr) 2007-10-11
JP2008529543A (ja) 2008-08-07
US10494410B2 (en) 2019-12-03
US20160244493A1 (en) 2016-08-25
US20090215680A1 (en) 2009-08-27
CA2597020C (fr) 2016-08-23
JP5612248B2 (ja) 2014-10-22
EP1988167A3 (fr) 2009-02-18
CA2597020A1 (fr) 2006-08-24
EP1988167A2 (fr) 2008-11-05
EP1988167B1 (fr) 2020-04-01
EP1693458A1 (fr) 2006-08-23
WO2006087242A2 (fr) 2006-08-24

Similar Documents

Publication Publication Date Title
NL300869I2 (nl) Olaratumab
ATE408603T1 (de) Pyrazolylcarboxanilide
CR9974A (es) Gavión
DE602006000573D1 (de) Gleitelement
EP1775630A4 (en) BAG
DE602006012066D1 (de) Daraus
DE602006000257D1 (de) Elektronenstrahlsterilisator
DE602006011096D1 (de) Flanschverbindungsvorrichtung
EP1912680A4 (en) HER-2 PEPTIDE
ATE549324T1 (de) Tetrahydrobenzoxazine
EP1858914A4 (en) NETWORKS OF PEPTIDES
DK1848727T3 (da) Ibandronat polymorf b
DE112006002964A5 (de) Zweirichtungsreflektanzverteilungsmessgerät
DK1968623T3 (da) Bacteriocin-inducer-peptider
DK1945367T3 (da) Kødhakker
DE502005005839D1 (de) Feldgeerät
FI20050753L (fi) Uudet peptidit
DE102005052834B8 (de) Punktschweißklebverbindung
DE602006010652D1 (de) Tripodegleichlaufgelenk
ATE485368T1 (de) Hiv - impfung
FI20055168A0 (fi) Tomografiamenetelmä
AT501523A3 (de) Estrich
EP1939286A4 (en) NEW PEPTIDE
DE502006000445D1 (de) Mulchmähdeck
DE102006033170A8 (de) Einfassnähmaschine